细胞毒性T淋巴细胞相关抗原4基因多态性与抗甲状腺药物所致白细胞减少的相关性

来源 :药物不良反应杂志 | 被引量 : 0次 | 上传用户:alsbzxx
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:研究中国北方汉族弥漫性毒性甲状腺肿(GD)患者细胞毒性T淋巴细胞相关抗原4(CTLA-4)第1外显子49位点A/G多态性与抗甲状腺药物(ATD)所致白细胞减少的相关性。方法:收集2009年10月至2010年6月到青岛大学医学院附属医院内分泌科就诊的GD患者(GD组)和同期到体检中心查体的健康人群(健康对照组)。GD组分为3个亚组:ATD治疗后白细胞减少组、ATD治疗后白细胞正常组和ATD治疗前白细胞减少组。收集所有研究对象外周非抗凝静脉血血凝块,提取基因组DNA,应用聚合酶链反应-限制性片段长度多态性技术测定CTLA-4基因第1外显子49位点基因型,抽取部分样本进行测序,并计算各组的基因型和等位基因频率。结果:GD组211例患者(ATD治疗后白细胞减少组73例,ATD治疗后白细胞正常组86例,GD合并白细胞减少组52例)、健康对照组85例纳入研究。GD组CTLA-4基因第1外显子49位点AA、AG和GG基因型频率分别为2.4%(5例)、38.8%(82例)、58.8%(124例),A、G等位基因频率分别为21.8%、78.2%;健康对照组AA、AG和GG的基因型频率分别为15.3%(13例)、32.9%(28例)和51.8%(44例),A和G的等位基因频率分别为31.8%和68.2%;2组的基因型和等位基因频率差异有统计学意义(χ~2=17.74,P=0.000 1;χ~2=6.48,P=0.01)。CTLA-4基因第1外显子49位点基因型和等位基因频率在ATD治疗后白细胞减少组、ATD治疗后白细胞正常组和GD合并白细胞减少组之间差异均无统计学意义(均P>0.05)。结论:中国北方汉族人群GD发病与CTLA-4基因第1外显子49位点A/G多态性相关,而ATD导致的白细胞减少似乎与其多态性无关。 Objective: To investigate the relationship between the A / G polymorphism at exon 49 of ATLA-4 and anti-thyroid drug (ATD) in patients with diffuse toxic goiter (GD) in North China. Related to leukopenia. Methods: The GD patients (GD group) and the healthy people (healthy control group) who went to the physical examination center in the same period were collected from October 2009 to June 2010 in the Department of Endocrinology, Affiliated Hospital of Qingdao University Medical College. GD group was divided into three subgroups: leukopenia group after ATD treatment, normal leukocyte group after ATD treatment and leukopenia group before ATD treatment. All the subjects were collected peripheral non-anticoagulant venous blood clotting, genomic DNA extraction, polymerase chain reaction - restriction fragment length polymorphism was used to detect CTLA-4 gene exon 49 49 locus genotypes, extraction part Samples were sequenced and genotype and allele frequencies were calculated for each group. Results: A total of 211 patients in the GD group (73 leukopenia patients after ATD treatment, 86 normal leukocyte patients after ATD treatment and 52 leukemia patients with GD) and 85 healthy controls were included in the study. The frequencies of AA, AG and GG genotypes in 49 loci of exon 1 of CTLA-4 gene in GD group were 2.4% (5 cases), 38.8% (82 cases), 58.8% (124 cases), A and G The genotype frequencies of AA, AG and GG were 15.3% (13 cases), 32.9% (28 cases) and 51.8% (44 cases) in healthy controls, respectively The frequencies of genotype and allele were 31.8% and 68.2% respectively in the two groups (χ ~ 2 = 17.74, P = 0.0001; χ ~ 2 = 6.48, P = 0.01). There was no significant difference in genotype and allele frequencies of CTLA-4 gene 49 locus between ATD-treated leukopenia group, ATD-treated leukocyte-normal group and GD-combined leukopenia group (all P > 0.05). CONCLUSIONS: The incidence of GD in Chinese Han population in northern China correlates with the A / G polymorphism at locus 49 of exon 1 of CTLA-4 gene. The leukopenia caused by ATD seems to be unrelated to its polymorphism.
其他文献
期刊
期刊
目的评价曲安奈德辅助玻璃体切除联合无染色内界膜剥除治疗Ⅳ期较大特发性黄斑孔的效果。方法对Ⅳ期特发性黄斑孔27例(27眼)常规行视力、眼压和光相干断层扫描(OCT)等检查确定黄斑孔的分期。手术采用曲安奈德染色玻璃体,行人工玻璃体后脱离术和无染色黄斑区内界膜剥除。手术后2周和3个月复查视力、眼压和OCT。对比手术前后视力、眼压和黄斑孔直径情况。结果手术前最佳矫正视力(logMAR)1.7~1.0,平均
目的:分析联合血液净化治疗对重症急性胰腺炎患者炎症因子的影响.方法:选取我院重症急性胰腺炎患者60例,时间区间为2016.3.30-2018.3.30,按照“简单随机”方式分组,每组 30
目的:探究外周动脉采血在新生儿护理中的应用效果.方法:选取2018年1月-2019年5月我院80例新生儿为研究对象,随机分为2组,每组40例,对照组实施股静脉穿刺采血,实验组实施外周
目的 观察比较紫杉醇联合奈达铂同期放化疗与奈达铂增敏放疗对食管癌的疗效及不良反应.方法 选择90例食管癌患者,按随机数字表法分为试验组(50例)和对照组(40例).试验组接受放疗联合紫杉醇及奈达铂化疗,对照组接受放疗联合奈达铂静脉滴注治疗,治疗4周后观察比较两组疗效和不良反应发生情况.结果 试验组总有效率和疾病控制率明显高于对照组[88.0%(44/50)比67.5%(27/40)、96.0%(4
重症急性胰腺炎(SAP)是临床常见的重症急腹症,病情凶险,病死率高.SAP治疗方法经历了从最初的积极外科手术治疗到个体化的内科综合非手术治疗,但目前国内外仍缺乏有效而规范的治疗方法.区域性动脉灌注(local arterialinfusion,LAI)是目前治疗SAP的一个热点,在各种治疗方法中具有一定的优势.一、LAI较静脉给药的优势Schmidt等[1 ]的实验表明,急性坏死性胰腺炎(ANP)
目的 分析内分泌失调合并糖尿病护理中应用健康教育干预的效果.方法 在2017年3月-2018年3月期间随机选择我院接收的86例内分泌失调合并糖尿病病患,平均分为两个治疗小组,对照
春季万物复苏,阳气生发,是踏青、赏花、看海、爬山、涉水亲近自然的最美好季节。你想过突破传统的旅行窠臼,在早春的明媚春光中,以SPA的形式开启一次心灵的洗礼吗?
期刊